GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easywell Biomedicals Inc (ROCO:1799) » Definitions » Net Income From Continuing Operations

Easywell Biomedicals (ROCO:1799) Net Income From Continuing Operations : NT$-33.5 Mil (TTM As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is Easywell Biomedicals Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Easywell Biomedicals's net income from continuing operations for the three months ended in Mar. 2025 was NT$-0.9 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-33.5 Mil.

Easywell Biomedicals Net Income From Continuing Operations Historical Data

The historical data trend for Easywell Biomedicals's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easywell Biomedicals Net Income From Continuing Operations Chart

Easywell Biomedicals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -182.82 -169.66 -168.28 -169.91 -88.29

Easywell Biomedicals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -55.65 -20.68 5.61 -17.57 -0.90

Easywell Biomedicals Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-33.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Easywell Biomedicals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easywell Biomedicals Inc (ROCO:1799) » Definitions » Net Income From Continuing Operations
Comparable Companies
ROCO:4166 TPE:4746 TPE:4119 ROCO:6932 ROCO:6785 ROCO:4120 ROCO:6576 TPE:1720 TPE:1731 ROCO:4747 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No.10, Yanfa 2nd Road, Hsinchu Science Park, 1st floor, Hsinchu, TWN, 30076
Website
https://www.easywellbio.com
Easywell Biomedicals Inc is engaged in drug development, manufacturing, and sales of active pharmaceutical ingredients and over-the-counter drug products The company's segment include the Drug development segment and Other segments.

Easywell Biomedicals Headlines

No Headlines